Anti- PI 3 Kinase p85 alpha (phospho Y467) + PI3 Kinase p55 (phospho Y199) antibody [PI3KY458-1A11] (Ab278545)
GRB1, PIK3R1, Phosphatidylinositol 3-kinase regulatory subunit alpha, PI3-kinase regulatory subunit alpha, PI3K regulatory subunit alpha, PtdIns-3-kinase regulatory subunit alpha, Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha, PI3-kinase subunit p85-alpha, PtdIns-3-kinase regulatory subunit p85-alpha, Phosphatidylinositol 3-kinase regulatory subunit gamma, PI3-kinase regulatory subunit gamma, PI3K regulatory subunit gamma, PtdIns-3-kinase regulatory subunit gamma, Phosphatidylino
详细信息
特异性
Recent data suggests this antibody can recognize PI 3 Kinase p85 and p55.
背景信息
What is this antibody validated in? Anti- PI 3 Kinase p85 alpha (phospho Y467) + PI3 Kinase p55 (phospho Y199) antibody [PI3KY458-1A11] (ab278545) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt) in Human, Mouse samples. What is the molecular weight of PI 3 Kinase p85 alpha? Anti- PI 3 Kinase p85 alpha (phospho Y467) + PI3 Kinase p55 (phospho Y199) [PI3KY458-1A11] (ab278545) specifically detects a band for PI 3 Kinase p85 alpha (UniProt: Q92569) at a molecular weight of 84kDa. Trusted by the scientific community Anti- PI 3 Kinase p85 alpha (phospho Y467) + PI3 Kinase p55 (phospho Y199) [PI3KY458-1A11] (ab278545) was first used in a scientific publication in 2021 and has been cited over 50 times in peer-reviewed journals. Other related products We have a range of other formats of antibody clone [PI3KY458-1A11] also available for your convenience: ab278545, PE - ab278691, FITC - ab278692, APC - ab278733 What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.
文献引用 (178)
TLR2-PI3K/Akt mediated microbe-mimetic priming boosts the therapeutic paracrine function of GelMA-Encapsulated MSCs for diabetic wound regeneration.
TLR2-PI3K/Akt 介导的微生物模拟启动增强了 GelMA 封装的 MSC 的治疗性旁分泌功能,用于糖尿病伤口再生。
Targeting the SOX9/TIMP1 Axis with iRGD-Conjugated Nanoplatform Enhances Dendritic Cell Function and Photodynamic Immunotherapy in Gastric Cancer.
利用 iRGD 偶联纳米平台靶向 SOX9/TIMP1 轴可增强树突状细胞功能和光动力免疫疗法在胃癌中的疗效。
Targeting FN1 to overcome gemcitabine resistance in gallbladder cancer: Mechanistic insights and an iRGD-modified PEG-PLGA nanoparticle delivery strategy.
靶向 FN1 以克服胆囊癌吉西他滨耐药性:机制见解和 iRGD 修饰的 PEG-PLGA 纳米颗粒递送策略。
Suppression of ASNS expression by VHL-mediated ubiquitination hinders the progression of renal cell carcinoma through enhancing JUP expression and inhibiting PI3K-AKT and MAPK pathways.
VHL介导的泛素化抑制ASNS表达,通过增强JUP表达和抑制PI3K-AKT和MAPK通路,阻碍肾细胞癌的进展。
PD‑L1 deficient exosomes derived from lung cancer cell line enhances NK cell‑mediated anti‑tumor immunity against lung cancer
源自肺癌细胞系的PD-L1缺陷型外泌体可增强NK细胞介导的抗肺癌免疫反应
OSMR coordinates a self-perpetuating circuit linking chemoresistance and neutrophil-driven immunosuppression in gastric cancer.
OSMR 协调一个自我延续的回路,将胃癌中的化疗耐药性和中性粒细胞驱动的免疫抑制联系起来。
HSP90AA1 restrains clear cell renal cell carcinoma progression by promoting CADM1 expression and suppressing the PI3K-AKT pathway through interaction with FBXO7.
HSP90AA1 通过与 FBXO7 相互作用,促进 CADM1 表达并抑制 PI3K-AKT 通路,从而抑制透明细胞肾细胞癌的进展。
Synergistic anti-hepatoma effect of triptolide and quercetin via co-inhibition and interaction with Janus kinase and mammalian target of rapamycin signal pathway.
雷公藤内酯醇和槲皮素通过与 Janus 激酶和哺乳动物雷帕霉素靶蛋白信号通路的共同抑制和相互作用,发挥协同抗肝癌作用。
The Dual Role of Gastrodin in Spinal Cord Injury: Microglial Phenotype Switching and Neuronal Survival via PI3K/AKT Activation.
天麻素在脊髓损伤中的双重作用:通过 PI3K/AKT 激活促进小胶质细胞表型转换和神经元存活。
LYVE-1 identifies asthma and drives PDGF-BB-induced proliferation, migration, and oxidative stress in airway smooth muscle cells via the PI3K/Akt pathway.
LYVE-1 可识别哮喘,并通过 PI3K/Akt 通路驱动 PDGF-BB 诱导的气道平滑肌细胞增殖、迁移和氧化应激。
- 1
- 2
- 3
- 4
- 5
- 6
- 18